Sonoco (SON) Q4 2025 earnings review
Transformation Complete: Leverage Target Hit, but Growth Resets
Sonoco has finalized its portfolio overhaul. With the divestiture of ThermoSafe in Q4 and TFP earlier in the year, the company met its aggressive deleveraging goal, hitting 3.0x Net Debt/EBITDA. Q4 financials were dominated by M&A noise: Revenue surged 30% largely due to the Eviosys acquisition (Consumer Packaging), while GAAP EPS skyrocketed on the sale gain. However, organic weakness persists in the Industrial segment (flat sales). FY26 guidance paints a mixed picture: Adjusted EPS is expected to grow ~5% at the midpoint, but Adjusted EBITDA guidance implies a slight year-over-year decline as the company digests divestitures.
🐂 Bull Case
Despite volume headwinds, Sonoco is extracting more profit from every dollar. Consumer Packaging Adjusted EBITDA margin expanded 110bps to 15.2%, and Industrial expanded to 18.2%. The 'value-based pricing' strategy is holding up.
The debt overhang is gone. Using ThermoSafe proceeds, Sonoco reduced net debt by $965M in Q4 alone, hitting a 3.0x leverage ratio. This significantly reduces interest expense risk and opens the door for buybacks or reinvestment in FY26.
🐻 Bear Case
The Industrial Paper Packaging segment is treading water. Sales were flat at $568M in Q4, with volume declines offsetting price gains. As a core segment, lack of volume growth here is a drag on the broader recovery story.
FY25 Free Cash Flow fell to $393M from $456M in the prior year. While divestiture taxes played a role, working capital needs (specifically inventory) remain a pressure point.
⚖️ Verdict: ⚪
Neutral/Hold. The strategic transformation is executed well—the balance sheet is clean and margins are healthy. However, the FY26 guidance suggests a 'digestive' year with flat-to-down EBITDA. Investors need to see organic volume growth return before re-rating the stock higher.
Key Themes
Consumer Segment Explosion
The Eviosys acquisition has fundamentally shifted Sonoco's weight. Consumer Packaging sales grew 62.1% YoY to $1.14B in Q4, now double the size of the Industrial segment. Crucially, this scale is coming with margin expansion (15.2% vs 14.1%), proving the synergy thesis is beginning to work.
Operational Efficiency Streak
The Industrial Paper Packaging segment has delivered margin expansion for nine consecutive quarters. In Q4, despite flat sales and volume declines, Adjusted EBITDA margin rose to 18.2% from 17.9%. Management attributes this to 'productivity from procurement savings and fixed cost reduction,' masking the demand weakness.
Revenue Reset in FY26
Guidance for FY26 Revenue is $7.25B - $7.75B. The midpoint ($7.50B) is effectively flat compared to FY25 ($7.52B). While expected due to the ThermoSafe divestiture, it highlights that the remaining 'New Sonoco' faces organic growth challenges to replace the lost top-line contribution.
Inventory Build-Up
Despite the divestitures and focus on efficiency, Inventories rose to $1.12B in 25Q4 from $1.02B a year ago. Management cited working capital needs for Metal Packaging EMEA, but in a flat volume environment, rising inventory warrants monitoring for potential future write-downs or production cuts.
Simplification Finalized
The 'All Other' segment is effectively dead. With the sale of ThermoSafe and the movement of industrial plastics into Industrial Paper Packaging, Sonoco will report only two segments in 2026. This increases transparency but removes the diversification buffer that 'All Other' provided.
Other KPIs
Target Achieved. Down from ~3.8x earlier in the year. The $2.7B reduction in net debt over the full year (aided by divestitures) is the most significant financial achievement of 2025.
Decelerating. Down 14% YoY from $456M in FY24. The drop was exacerbated by $196M in one-time taxes on divestitures, but operating cash flow also dipped due to working capital drags.
Stable. Up 5% YoY ($1.00). While positive, it lags the 10% EBITDA growth, reflecting that interest expenses and tax rates are eating into the operational improvements.
Guidance
Accelerating. Midpoint ($6.00) implies +5% growth vs FY25 ($5.71). This is driven largely by reduced interest expense from the debt paydown rather than explosive operational growth.
Decelerating/Reversing. The midpoint ($1.30B) is slightly below the FY25 actual of $1.324B. The loss of ThermoSafe earnings is outweighing the expected synergies from Eviosys and organic growth.
Accelerating. Midpoint ($750M) is an improvement over the $690M generated in FY25 (which was weighed down by tax payments). Suggests better conversion in the simplified portfolio.
Key Questions
Organic Volume in Industrial
Industrial sales were flat despite price increases, implying volume declines. With the 'destocking' narrative largely over for the broader industry, why is volume still dragging, and when does it turn positive?
Eviosys Synergy Realization
With the integration of Eviosys now fully underway, are you seeing the $100M synergy target accelerating, or is the macro softness in Europe pushing this timeline to the right?
Capital Allocation Shift
Now that the 3.0x leverage target is hit, will FY26 see a pivot to share buybacks, or is the focus purely on internal CAPEX to drive organic growth?
Tariff Exposure Impact
Management mentioned tariffs as a driver for price increases. Given the new geopolitical landscape, what is the net exposure on raw material imports versus pricing power to pass these through?